401 filings
Page 12 of 21
8-K
xhi5g3
9 Aug 04
Oscient Pharmaceuticals Reports Financial Results for Second Quarter of 2004
12:00am
S-8
vsadqar wi
21 Jun 04
Registration of securities for employees
12:00am
8-K
trasudtofhnj1vugj
26 May 04
Oscient Pharmaceuticals Closes Initial Purchasers’ Option for Convertible Notes Offering
12:00am
8-K
3fabx79pvsx2wkrectg
14 May 04
Oscient Pharmaceuticals Reports Financial Results for First Quarter of 2004
12:00am
424B3
cad0um5lo
12 May 04
Prospectus supplement
12:00am
8-K
38yf3wnzhje7onawxgdl
11 May 04
Oscient Pharmaceuticals Completes $125 Million Convertible Notes Offering
12:00am
8-K
oved4juye
5 May 04
Oscient Pharmaceuticals Announces Pricing of
12:00am
8-K
nr8guel1q4tpnz954w
3 May 04
Oscient Pharmaceuticals Proposes $75 Million Convertible Notes Offering
12:00am
8-K/A
h3zesd92s 6aoz5
16 Apr 04
Report of Independent Auditors
12:00am
8-K
n7h sd3v1lmj
14 Apr 04
Other events
12:00am
8-K
0r37ipd5c16mg
8 Mar 04
Current report
12:00am
REGDEX
8ed484rf1 f9
23 Feb 04
Notice of sale of securities
12:00am
S-8
wat3sh cdzicn
13 Feb 04
Registration of securities for employees
12:00am
8-K
7p1d4ke
10 Feb 04
Genome Therapeutics and Genesoft Pharmaceuticals Complete Merger to Form Biopharmaceutical Company Focused on Anti-Infectives
12:00am